Physician-Pharmacist Collaboration for Osteoporotic Patient Follow-up

Completed

• Conditions: Osteoporosis

• Registration Number: NCT02892188
• Lead Sponsor: Centre Hospitalier Régional Metz-Thionville

Brief Summary

The purpose of this study is to evaluate the follow-up of the osteoporotic patient by a physician-pharmacist collaboration.

Detailed Description

Treatments allow decreasing the personal fracture risk from 48% to 85% provided that the treatment period is continued at least 3 to 5 years and that hygienic and dietary measures are applied: optimization of the dietary calcium intakes (much more efficient and less dangerous than the medicinal intakes), preservation of a physical activity, fall prevention. The ability of bisphosphonate for decreasing significantly the number of fractures was proved, but the lack of lasting adhesion (persistence) and of flanking measures leads to believe their efficiency may be enhanced: the hip-fracture rate decreases from 2.1% for the non-adherents to 1,3% for the patients with observance, which represents a one-half reduction.

The cost of surgery for a femoral neck fracture is estimated at 8500 euros. So the prevention of only one femoral neck fracture entails a huge economy.

However, 50% of women stop their treatment before a year and the implementation of hygienic and dietary measures leads to a lifestyle change, and faces long time ingrained habits. Only 42% of patients continue their treatment after two years, and only 16% after three years.

Study Timeline

• Study Start: 2013-01
• Study First Submitted: 2016-08-26
• Study First Submitted QC: 2016-09-01
• Study First Posted: 2016-09-08
• Primary Completion: 2019-01
• Study Completion: 2019-02
• Status Verified: 2019-12
• Last Update Submitted: 2019-12-31
• Last Update Posted: 2020-01-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• older than 18 years old
• having an osteoporosis treatment
• following a Therapeutical Education for Patient

Exclusion Criteria

• opposition for anonymised data gathering

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Respect of treatment and of hygienic dietary measures by patients with a self-questionnaire per medical check	year 3	This assessment will be made at the end of the follow-up, after three years, but an intermediary assessment about those same criteria is planned at one and two years of the follow-up.

Secondary Outcome Measures

Name	Time	Method
Qualitative evaluation of the professional adhesion for the follow-up process once a year during the annual meeting	year 3	This assessment will be made at the end of the follow-up, after three years, but an intermediary assessment about those same criteria is planned at one and two years of the follow-up.
Quantitative evaluation of it by the return rate of questionnaires	year 3	This assessment will be made at the end of the follow-up, after three years, but an intermediary assessment about those same criteria is planned at one and two years of the follow-up.

Trial Locations

Locations (1)

CHR Metz-Thionville; 🇫🇷 Metz Cedex 03, France